Pressure BioSciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Fair Value Assumptions (Details)

Summary of Significant Accounting Policies - Schedule of Fair Value Assumptions (Details) - $ / shares		6 Months Ended	12 Months Ended
	Nov. 10, 2011	Jun. 30, 2016	Dec. 31, 2015
Expected life (in months)	60 months
Expected volatility	104.50%
Risk-free interest rate	0.875%
Exercise price	$ 0.81
Fair value per share	$ 0.54
Warrants Revalued at December 31, 2015 [Member]
Exercise price			$ 0.40
Fair value per share			$ 0.30
Warrants Revalued at December 31, 2015 [Member]
Expected life (in months)			11 months
Expected volatility			104.90%
Risk-free interest rate			0.65%
Exercise price			$ .25
Fair value per share			$ 0.16
Warrants Revalued at December 31, 2015 [Member] \| Warrants Issued with Convertible Debt [Member] \| Minimum [Member]
Expected life (in months)			55 months
Expected volatility			136.30%
Risk-free interest rate			1.29%
Warrants Revalued at December 31, 2015 [Member] \| Warrants Issued with Convertible Debt [Member] \| Maximum [Member]
Expected life (in months)			60 months
Expected volatility			141.60%
Risk-free interest rate			1.76%
Warrants Revalued at June 30, 2016 [Member]
Expected life (in months)		4 months
Expected volatility		96.20%
Risk-free interest rate		0.26%
Exercise price		$ 0.25
Fair value per share		0.16
Warrants Revalued at June 30, 2016 [Member] \| Warrants Issued with Convertible Debt [Member]
Exercise price		$ 0.40
Warrants Revalued at June 30, 2016 [Member] \| Warrants Issued with Convertible Debt [Member] \| Minimum [Member]
Expected life (in months)		48 months
Expected volatility		137.90%
Risk-free interest rate		1.01%
Fair value per share		$ 0.32
Warrants Revalued at June 30, 2016 [Member] \| Warrants Issued with Convertible Debt [Member] \| Maximum [Member]
Expected life (in months)		60 months
Expected volatility		142.20%
Risk-free interest rate		1.21%
Fair value per share		$ 0.40
Issuance Fair Value [Member] \| Minimum [Member]
Expected life (in months)		3 months
Expected volatility		97.60%
Risk-free interest rate		0.37%
Exercise price		$ 0.24
Fair value per share		$ 0.07
Issuance Fair Value [Member] \| Maximum [Member]
Expected life (in months)		24 months
Expected volatility		153.80%
Risk-free interest rate		0.99%
Exercise price		$ 0.45
Fair value per share		$ 0.30
Issuance Fair Value [Member] \| Warrants Issued with Convertible Debt [Member] \| Minimum [Member]
Expected life (in months)		36 months
Expected volatility		114.30%
Risk-free interest rate		0.86%
Exercise price		$ 0.40
Fair value per share		$ 0.19
Issuance Fair Value [Member] \| Warrants Issued with Convertible Debt [Member] \| Maximum [Member]
Expected life (in months)		60 months
Expected volatility		138.30%
Risk-free interest rate		1.69%
Exercise price		$ 0.42
Fair value per share		$ 0.40
Conversion Options Revalued at December 31, 2015 [Member]
Risk-free interest rate			1.06%
Exercise price			$ 0.28
Conversion Options Revalued at December 31, 2015 [Member] \| Minimum [Member]
Expected life (in months)			18 months
Expected volatility			112.20%
Fair value per share			$ 0.14
Conversion Options Revalued at December 31, 2015 [Member] \| Maximum [Member]
Expected life (in months)			24 months
Expected volatility			114.70%
Fair value per share			$ 0.33
Conversion Options Revalued at June 30, 2016 [Member] \| Minimum [Member]
Expected life (in months)		6 months
Expected volatility		94.80%
Risk-free interest rate		0.36%
Exercise price		$ 0.28
Fair value per share		$ 0.08
Conversion Options Revalued at June 30, 2016 [Member] \| Maximum [Member]
Expected life (in months)		24 months
Expected volatility		113.67%
Risk-free interest rate		0.73%
Exercise price		$ 0.45
Fair value per share		$ 0.30